Publication | Open Access

The EORTC Tables Overestimate the Risk of Recurrence and Progression in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: External Validation of the EORTC Risk Tables

External ValidationSurgical OncologyUrologyCancer EpidemiologyUrologic Cancer EpidemiologyGenitourinary CancerMedicineCancer ManagementCancer RiskUrological ResearchPopulation Health SciencesPublic HealthOncologyRadiation OncologyEortc Risk TablesCancer ResearchEortc Tables Overestimate